This inventor holds 27 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 14 EPO patents, primarily in Glucocorticoid Receptor Modulators. Top assignees: Corcept Therapeutics Incorporated, Astrazeneca Ab, Respivert Limited. Active years: 2005-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Charnwood, GB (2006)
- Loughborough, GB (2005 - 2021)
- Nottingham, GB (2014 - 2023)
Company Filing History:
15 out of 138 
6 out of 1,534 
6 out of 63 
Years Active: 2005-2025
Areas of Expertise:
Title: The Innovative Journey of Inventor Iain Walters
Introduction: Iain Walters, an accomplished inventor based in Nottingham, GB, has made significant contributions to the field of pharmaceuticals, holding an impressive portfolio of 27 patents. His work primarily focuses on developing novel compounds that serve as glucocorticoid receptor modulators, showcasing his commitment to advancing medical science.
Latest Patents: Among his latest innovations are two noteworthy patents:
1. **Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators** - This invention presents heteroaryl ketone fused azadecalin compounds, along with methods for their use as glucocorticoid receptor modulators. Importantly, these compounds have potential applications in treating amyotrophic lateral sclerosis (ALS).
2. **Octahydro fused azadecalin glucocorticoid receptor modulators** - This patent provides details on octahydro fused azadecalin compounds and outlines methods for employing these compounds as glucocorticoid receptor modulators.
Career Highlights: Iain has worked with leading companies in the pharmaceutical industry, such as Corcept Therapeutics Incorporated and AstraZeneca AB. His affiliations with these organizations demonstrate his crucial role in pioneering innovative solutions in drug development.
Collaborations: Throughout his career, Iain has collaborated with notable colleagues, including Hazel Joan Hunt and Tony Johnson. These partnerships have likely contributed to the enhancement and expansion of his inventive projects.
Conclusion: Iain Walters exemplifies the spirit of innovation in the pharmaceutical realm. With a strong track record of patents focused on glucocorticoid receptor modulators, he stands as a testament to the potential of inventive minds in shaping the future of medicine. His ongoing contributions continue to inspire and influence the healthcare landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile